eastman kodak said plan sell it pct hold icn pharmaceut and part it nine pct hold viratek said purpos invest had been lay groundwork for creation it nucleic acid research institut sinc has been achiev longer ani reason maintain equiti posit kodak said kodak hold 470 000 sahr icn current trade about and 700 000 viratek trade reuter 